73 results
8-K
EX-99.1
ATHA
Athira Pharma Inc
15 May 24
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
4:10pm
in a progressive mild-to-moderate Alzheimer’s disease population.
Athira believes the OLEX will complement its long-term safety database and provide … insights into fosgonimeton’s long-term effects for potentially over four years of investigational treatment.
SHAPE Phase 2 clinical trial of fosgonimeton
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
employees at the executive level who contribute to our long-term success;
provide compensation packages to our executives that are fair and competitive … of our stockholders by focusing on long-term equity incentives that correlate with the growth of sustainable long-term value for our stockholders.
Our
8-K
EX-99.1
8mtem5dwj0bw6i
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
uygadsu6
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
EX-99.1
67ezamb
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
75pq8g9mtchdj2
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-10.2
tumickt2nm38dkh
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-99.1
sxfqktm
11 May 23
Athira Pharma Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
ylh4krbsd2oj5wu
10 Nov 22
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:11pm
8-K
EX-99.1
2bl94n7
15 Aug 22
Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:35pm